New treatment option for Parkinson Disease
Official title Telerehabilitation Dual-Task Training for Parkinson's: A Multidimensional Evaluation
ClinicalTrials.gov ID: NCT06416722
What this study is testing
- What it's testing
- In this clinical study, the aim is to assess the effectiveness of telerehabilitation-based dual-task training in improving balance and gait function among individuals diagnosed with Parkinson's Disease. Parkinson's Disease is characterized by motor symptoms such as tremors and slowness of movement, as well as cognitive impairments.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 75
You may be able to join if
- Diagnosed with idiopathic Parkinson's Disease
- Stage 1-3 on the Hoehn-Yahr scale
- A minimum score of 21 on the Montreal Cognitive Assessment Scale test
- Stable drug treatment within the last 1 month
- Patients are in the "On" period
You likely can't join if
- Serious hearing or vision problems
- Having other neurological, cardiovascular or orthopaedic disorders that may prevent walking
- Any other neurological disorder (e.g. dementia, cerebrovascular disease)
- less than 5 years of education
- To have vascular lower extremity pathologies
- Not having internet access via smartphone or computer
See the full eligibility criteria
- Diagnosed with idiopathic Parkinson's Disease
- Stage 1-3 on the Hoehn-Yahr scale
- A minimum score of 21 on the Montreal Cognitive Assessment Scale test
- Stable drug treatment within the last 1 month
- Patients are in the "On" period
- Ability to walk independently on level ground (3 and above according to Functional Ambulation Classification)
- Serious hearing or vision problems
- Having other neurological, cardiovascular or orthopaedic disorders that may prevent walking
- Any other neurological disorder (e.g. dementia, cerebrovascular disease)
- less than 5 years of education
- To have vascular lower extremity pathologies
- Not having internet access via smartphone or computer
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Bakırköy, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 30 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Bakırköy, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.